KRAS mutation

Last revised by Rohit Sharma on 17 Nov 2021

KRAS (shortened name for the gene Kirsten RAt Sarcoma viral oncogene homolog) mutations are associated in a number of malignancies including: 

Several germline KRAS mutations have also been found to be associated with some syndromes such as:

The gene provides instructions for a protein called K-Ras, which is part of a signaling pathway (RAS/MAPK pathway), instructing the cell to grow and divide, or to mature and take on specialized functions (i.e. differentiate).

See also

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.